Novel chemotherapeutic regimens for NK/T-cell lymphomas
Regimen . | Protocol . | Reference . |
---|---|---|
AspaMetDex | Escherichia colil-asparaginase: 6000 U/m2 IM, days 2, 4, 6, and 8 | 16 |
Methotrexate: 3000 mg/m2 IV, day 1 | ||
Dexamethasone: 40 mg orally, days 1-4 | ||
2/3DeVIC | Dexamethasone: 40 mg IV, days 1-3 | 56 |
Etoposide: 67 mg/m2 IV, days 1-3 | ||
Ifosfamide: 1000 mg/m2 IV, days 1-3 | ||
Carboplatin: 200 mg/m2 IV, day 1 | ||
VIPD | Etoposide: 100 mg/m2 IV, days 1-3 | 57 |
Ifosfamide: 1200 mg/m2 IV, days 1-3 | ||
Cisplatin: 33 mg/m2 IV, days 1-3 | ||
Dexamethasone: 40 mg IV or orally, days 1-4 | ||
LVP | l-asparaginase: 6000 IU/m2 IV, days 1-5 | 59 |
Vincristine: 1.4/m2 IV, day 1 | ||
Prednisolone: 100 mg orally, days 1-5 | ||
GELOX | Gemcitabine: 1000 mg/m2 IV, days 1 and 8 | 60 |
E. colil-asparaginase: 6000 units/m2 IM, days 1-7 | ||
Oxaliplatin: 130 mg/m2 IV, day 1 | ||
SMILE | Dexamethasone: 40 mg IV or orally, days 2-4 | 62 |
Methotrexate: 2000 mg/m2 IV, day 1 | ||
Ifosfamide: 1500 mg/m2 IV, days 2-4 | ||
E. colil-asparaginase: 6000 U/m2 IV, days 8, 10, 12, 14, 16, 18, and 20 | ||
Etoposide: 100 mg/m2 IV, days 2-4 |
Regimen . | Protocol . | Reference . |
---|---|---|
AspaMetDex | Escherichia colil-asparaginase: 6000 U/m2 IM, days 2, 4, 6, and 8 | 16 |
Methotrexate: 3000 mg/m2 IV, day 1 | ||
Dexamethasone: 40 mg orally, days 1-4 | ||
2/3DeVIC | Dexamethasone: 40 mg IV, days 1-3 | 56 |
Etoposide: 67 mg/m2 IV, days 1-3 | ||
Ifosfamide: 1000 mg/m2 IV, days 1-3 | ||
Carboplatin: 200 mg/m2 IV, day 1 | ||
VIPD | Etoposide: 100 mg/m2 IV, days 1-3 | 57 |
Ifosfamide: 1200 mg/m2 IV, days 1-3 | ||
Cisplatin: 33 mg/m2 IV, days 1-3 | ||
Dexamethasone: 40 mg IV or orally, days 1-4 | ||
LVP | l-asparaginase: 6000 IU/m2 IV, days 1-5 | 59 |
Vincristine: 1.4/m2 IV, day 1 | ||
Prednisolone: 100 mg orally, days 1-5 | ||
GELOX | Gemcitabine: 1000 mg/m2 IV, days 1 and 8 | 60 |
E. colil-asparaginase: 6000 units/m2 IM, days 1-7 | ||
Oxaliplatin: 130 mg/m2 IV, day 1 | ||
SMILE | Dexamethasone: 40 mg IV or orally, days 2-4 | 62 |
Methotrexate: 2000 mg/m2 IV, day 1 | ||
Ifosfamide: 1500 mg/m2 IV, days 2-4 | ||
E. colil-asparaginase: 6000 U/m2 IV, days 8, 10, 12, 14, 16, 18, and 20 | ||
Etoposide: 100 mg/m2 IV, days 2-4 |
IM, intramuscularly.